Vitamin B12 may be more effective than nortriptyline in improving painful diabetic neuropathy

International Journal of Food Sciences and Nutrition

Volumn 60, Issue SUPPL. 5, 2009, Pages 71-76

  Talaei, Afsaneh ^a   Siavash, Mansour ^b   Majidi, Hamid ^b   Chehrei, Ali ^c  

^a ARAK UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Nortriptyline; Painful diabetic neuropathy; Vitamin B12

Indexed keywords

ANALGESIC AGENT; ANTICONVULSIVE AGENT; CYANOCOBALAMIN; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; LIPID; NORTRIPTYLINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MIDDLE AGED; NERVE CELL; NERVE CONDUCTION; NEURALGIA; PAIN ASSESSMENT; PARESTHESIA; PATHOPHYSIOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TIME;

ADOLESCENT; ADULT; ANALGESICS, NON-NARCOTIC; ANTICONVULSANTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; BLOOD GLUCOSE; DIABETIC NEUROPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, INTRAMUSCULAR; LIPIDS; MALE; MIDDLE AGED; NEURAL CONDUCTION; NEURALGIA; NEURONS; NORTRIPTYLINE; PAIN MEASUREMENT; PARESTHESIA; QUESTIONNAIRES; TIME FACTORS; VITAMIN B 12; YOUNG ADULT;

EID: 77951429536     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637480802406153     Document Type: Article

References (19)

1. Bastias AM, Toro CL, Olmos CP. 2006. Intensified insulin therapy plus antineuritic medication is more effective than antineuritics alone in painful diabetic neuropathy. Rev Med Chil 134:1507-1515.
2. Beydoun S, Alarcon F, Mangat S, Wan Y. 2007. Long-term safety and tolerability of oxcarbazepine in painful diabetic neuropathy. Acta Neurol Scand 115:284-288.
3. Ambrosch A, Dierkes J, Lobmann R, Kuhne W, Konig W, Luley C, Lehnert H. 2001. Relation between homocysteinaemia and diabetic neuropathy in patients with type 2 diabetes mellitus. Diabet Med 18:185-192. (Pubitemid 32397855)
4. Christianson JA, Ryals JM, Johnson MS, Dobrowsky RT, Wright DE. 2007. Neurotrophic modulation of myelinated cutaneous innervation and mechanical sensory loss in diabetic mice. Neuroscience 145:303- 313.
5. Donnan J, Ledger S. 2006. An update on the treatment and management of diabetic peripheral neuropathy. CANNT J 16:32-36.
6. Edwards JL, Vincent AM, Cheng HL, Feldman EL. 2008. Diabetic neuropathy: Mechanisms to management. Pharmacol Ther 120:1-34.
7. Foster TS. 2007. Efficacy and safety of a-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy. Diabetes Educ 33:111-117.
8. Gonin JM, Nguyen H, Gonin R, Sarna A, Michels A, Masri-Imad F, Bommareddy G, Chassaing C, Wainer I, Loya A, Cary D, Barker LF, Assefi A, Greenspan R, Mahoney D, Wilcox CS. 2003. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD. J Nephrol 16:522-534.
9. Hvas AM, Ellegaard J, Nexo E. 2001. Vitamin B12 treatment normalizes metabolic markers but has limited clinical effect: a randomized placebo-controlled study. Clin Chem 47:1396-1404.
10. Ide H, Fujiya S, Asanuma Y, Tsuji M, Sakai H, Agishi Y. 1987. Clinical usefulness of intrathecal injection of methylcobalamin in patients with diabetic neuropathy. Clin Ther 9:183-192.
11. Koyama K, Usami T, Takeuchi O, Morozumi K, Kimura G. 2002. Efficacy of methylcobalamin on lowering total homocysteine plasma concentrations in haemodialysis patients receiving high-dose folic acid supplementation. Nephrol Dial Transplant 17:916-922.
12. Kuwabara S, Nakazawa R, Azuma N, Suzuki M, Miyajima K, Fukutake T, Hattori T. 1999. Intravenous methylcobalamin treatment for uremic and diabetic neuropathy in chronic hemodialysis patients. Intern Med 38:472-475.
13. Martin CL, Albers J, Herman WH, Cleary P, Waberski B, Greene DA, Stevens MJ, Feldman EL. 2006. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. Diabetes Care 29:340-344.
14. Moron De Salim AR, Garces PA. 2005. Effect of the supplementation of vitamins B12, B6 and folic acid on homocysteine and plasmatic lipids in patients with hyperlipoproteinemic secondary type IV. Arch Latinoam Nutr 55:28-33.
15. Pongchaidecha M, Srikusalanukul V, Chattananon A, Tanjariyaporn S. 2004. Effect of metformin on plasma homocysteine, vitamin B12 and folic acid: A cross-sectional study in patients with type 2 diabetes mellitus. J Med Assoc Thai 87:780-787.
16. Sanchez Alvarez JE, Perez TL, Hernandez D, Alvarez GA, Delgado P, Lorenzo V. 2005. Efficacy and safety of two vitamin supplement regimens on homocysteine levels in hemodialysis patients. Prospective, randomized clinical trial. Nefrologia 25:288-296.
17. Stracke H, Lindemann A, Federlin K. 1996. A benfotiamine-vitamin B combination in treatment of diabetic polyneuropathy. Exp Clin Endocrinol Diabetes 104:311-316.
18. Sun Y, Lai MS, Lu CJ. 2005. Effectiveness of vitamin B12 on diabetic neuropathy: Systematic review of clinical controlled trials. Acta Neurol Taiwan 14:48-54.
19. Yaqub BA, Siddique A, Sulimani R. 1992. Effects of methylcobalamin on diabetic neuropathy. Clin Neurol Neurosurg 94:105-111.